Bard’s New Trial Request Rejected Over $3.6 million Verdict
Bard’s New Trial Request Rejected Over $3.6 million Verdict

Introduction
An Arizona federal judge rejected C.R.Bard's appeal for a new trial and judgment in a $3.6 million verdict awarded to a woman, who suffered complications due to fracture and migration of the G2 IVC filter.
The plaintiff was implanted with the IVC filter in 2007, which gradually broke, tilted and migrated, causing injuries to her inferior vena cava. She filed a lawsuit against the manufacturer for being negligent in providing adequate warning about the faulty device to her doctors. The U.S. District Court, District of Arizona found C.R. Bard liable for the woman's complications. The plaintiff was awarded $1.6 million in actual damages and $2 million in punitive damages in March. The company stated that the plaintiff had “utterly failed to present any evidence at the trial on the fundamental premise” of negligent failure to warn.
Bard called the jury's verdict “irreconcilably inconsistent" and filed motions for a new trial and a judgment as a matter of law on April 23rd. On June 19, 2018, Judge David Campbell rejected both arguments by Bard, and stated: “the focus in negligence is on the manufacturer’s conduct, while in strict liability it is on the product and the user’s expectations.”
More than 4,000 IVC filter product liability lawsuits are federally-filed against C.R.Bard over claims including filter migration and organ perforation. Judge David G. Campbell overlooks the multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) formed on August 17, 2015, in the District of Arizona.
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…